Inotuzumab ozogamicin

WikiDoc Resources for Inotuzumab ozogamicin
Articles
Most recent articles on Inotuzumab ozogamicin Most cited articles on Inotuzumab ozogamicin Review articles on Inotuzumab ozogamicin Articles on Inotuzumab ozogamicin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Inotuzumab ozogamicin Images of Inotuzumab ozogamicin Photos of Inotuzumab ozogamicin Podcasts & MP3s on Inotuzumab ozogamicin Videos on Inotuzumab ozogamicin
Evidence Based Medicine
Cochrane Collaboration on Inotuzumab ozogamicin Bandolier on Inotuzumab ozogamicin TRIP on Inotuzumab ozogamicin
Clinical Trials
Ongoing Trials on Inotuzumab ozogamicin at Clinical Trials.gov Trial results on Inotuzumab ozogamicin Clinical Trials on Inotuzumab ozogamicin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Inotuzumab ozogamicin NICE Guidance on Inotuzumab ozogamicin NHS PRODIGY Guidance FDA on Inotuzumab ozogamicin CDC on Inotuzumab ozogamicin
Books
Books on Inotuzumab ozogamicin
News
Inotuzumab ozogamicin in the news Be alerted to news on Inotuzumab ozogamicin News trends on Inotuzumab ozogamicin
Commentary
Blogs on Inotuzumab ozogamicin
Definitions
Definitions of Inotuzumab ozogamicin
Patient Resources / Community
Patient resources on Inotuzumab ozogamicin Discussion groups on Inotuzumab ozogamicin Patient Handouts on Inotuzumab ozogamicin Directions to Hospitals Treating Inotuzumab ozogamicin Risk calculators and risk factors for Inotuzumab ozogamicin
Healthcare Provider Resources
Symptoms of Inotuzumab ozogamicin Causes & Risk Factors for Inotuzumab ozogamicin Diagnostic studies for Inotuzumab ozogamicin Treatment of Inotuzumab ozogamicin
Continuing Medical Education (CME)
CME Programs on Inotuzumab ozogamicin
International
Inotuzumab ozogamicin en Espanol Inotuzumab ozogamicin en Francais
Business
Inotuzumab ozogamicin in the Marketplace Patents on Inotuzumab ozogamicin
Experimental / Informatics
List of terms related to Inotuzumab ozogamicin

Overview

Inotuzumab ozogamicin is a humanized monoclonal antibody and which is used to treat cancers. Inotuzumab has a chelator, ozogamicin, same as in gemtuzumab.

Template:Humanizedmonoclonals